Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

The Significance of Microbial Metabolomics in Human Health and Disease

WEBINAR

Only

The Significance of Microbial Metabolomics in Human Health and Disease

Tuesday, November 10, 2020, 11:00 AM - 4:45 PM EST

WEBINAR

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Metabolomics has emerged as a new approach to study the mechanisms of human disease and health maintenance. This field of study can include the microbiome, where products of microbial metabolism may serve as molecular intermediaries—traveling beyond the microbes’ resident organ (e.g., the intestine) and propagating downstream physiologic effects throughout the body. These metabolites therefore provide several exciting nodes for therapeutic intervention, and may also serve as important biomarkers for disease. But identifying causative metabolic products associated with health outcomes remains a challenge. This symposium will explore the promise of microbial metabolomics, and will provide an opportunity for leaders from academia and industry to share the latest advancements in the field.

Registration

Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Deadline:
0
days
left

Scientific Organizing Committee

Steven Gross, PhD

Weill Cornell Medicine

John Hambor, PhD

Boehringer Ingelheim

Nilufer Seth, PhD

Janssen

Sonya Dougal, PhD

New York Academy of Sciences

Kari Fischer, PhD

New York Academy of Sciences

Keynote Speaker

Rima Kaddurah-Daouk, PhD
Rima Kaddurah-Daouk, PhD

Duke University School of Medicine

Speakers

Janelle S. Ayres
Janelle S. Ayres, PhD

Salk Institute for Biological Studies

Priyanka Baloni
Priyanka Baloni, PhD

Institute for Systems Biology, Seattle

Jane Ferguson
Jane Ferguson, PhD

Vanderbilt University Medical Center

Michael A. Fischbach
Michael A. Fischbach, PhD

Stanford University

Wendy Garrett, MD, PhD
Wendy Garrett, MD, PhD

Harvard T.H. Chan School of Public Health

Sarkis Mazmanian
Sarkis Mazmanian, PhD

California Institute of Technology

David Wishart
David Wishart, PhD

University of Alberta

Event Support


Program Supporters



Tuesday

November 10, 2020

11:00 AM

Welcome Remarks

Speaker

Kari Fischer, PhD
New York Academy of Sciences
11:15 AM

Keynote: Precision Medicine Approach for the Study of Neuropsychiatric Diseases - At the Cross Road of Exposome Gut Microbiome Genome and Metabolome

Speaker

Rima Kaddurah-Daouk, PhD
Duke University School of Medicine

Session 1

11:45 AM

New Data Resources for Microbial Metabolomics

Speaker

David Wishart, PhD
University of Alberta
12:15 PM

Small Molecules from the Human Microbiota

Speaker

Michael A. Fischbach, PhD
Stanford University
12:45 PM

Networking Break

1:00 PM

Effects of Microbial Metabolites on the Gastrointestinal Immune System in Inflammatory Bowel Disease and Colorectal Cancer

Speaker

Wendy Garrett, MD, PhD
Harvard T.H. Chan School of Public Health

Session 2: Early Career Spotlight

1:30 PM

Fibre-associated Lachnospiraceae Reduce Colon Tumorigenesis by Modulation of the Tumor-immune Microenvironment

Speaker

Ana S. Almeida, PhD
APC Microbiome Ireland, University College Cork
1:40 PM

Deciphering the Role of Skin Surface Microbiome on Skin Health: An Integrative Multi-omics Approach Reveals Three Distinct Microbial / Metabolic Clusters

Speaker

Pierre-François Roux, PhD
Johnson & Johnson Santé Beauté France
1:50 PM

Gut Microbiota Metabolome: Fused Omic Model and Network Analysis to Discover Microbiota-linked Biomarkers in Pediatric Diseases

Speaker

Pamela Vernocchi, PhD
Bambino Gesu’ Children’s Research Hospital IRCCS
2:00 PM

Networking Break

Session 3

2:30 PM

Host-Metabolic Adaptations in Host-Pathogen Interactions Regulate Pathogen Virulence

Speaker

Janelle Ayres, PhD
Salk Institute for Biological Studies
3:00 PM

Bile Acids as Metabolic Markers in Alzheimer's Disease

Speaker

Priyanka Baloni, PhD
Institute for Systems Biology, Seattle
3:30 PM

Networking Break

3:45 PM

Diet and Microbial-Derived Metabolites in Hypertension and Cardiometabolic Disease

Speaker

Jane Ferguson, PhD
Vanderbilt University Medical Center
4:15 PM

A Gut Microbial Metabolite Regulates Oligodendrocyte Maturation and Emotional Behaviors in Mice

Speaker

Sarkis Mazmanian, PhD
California Institute of Technology
4:45 PM

Closing Remarks & Event Concludes

Loading...